About MALARONE PEDIATRIC

MALARONE PEDIATRIC is a pediatric formulation of the antimalarial medication, designed to treat and prevent malaria in children. It contains a combination of atovaquone and proguanil hydrochloride, two active ingredients that work synergistically to combat the disease.

Key Benefits & Uses

Treatment and prevention of malaria caused by Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae.
Recommended for children aged 2 months and above, weighing at least 5 kg.
Effective against chloroquine-resistant strains of P. falciparum.

Active Ingredient & Action

The active ingredients in MALARONE PEDIATRIC work together to inhibit the growth and replication of malaria parasites in the body. Atovaquone targets the parasite's mitochondrial electron transport chain, while proguanil hydrochloride inhibits the parasite's dihydrofolate reductase enzyme, ultimately leading to the death of the parasite.

Important Notes

It is essential to consult a healthcare professional before administering MALARONE PEDIATRIC to children. The medication should be taken exactly as prescribed, and the full treatment course should be completed to ensure effective malaria prevention and treatment. MALARONE PEDIATRIC may interact with other medications, and patients should inform their healthcare provider of any other medications they are taking.